NCT07608718
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07608718
Title Phase II Trial of Zanzalitinib in Patients With Metastatic Castration Resistant Prostate Cancer
Recruitment Not yet recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Pedro Barata, MD, MSc
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center Cleveland Ohio 44106 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field